EPILEPSIA is a premier academic journal published by Wiley, with a storied history dating back to 1909, making it a cornerstone in the field of epilepsy research and neurology. With an impressive impact factor reflecting its robust contribution to the academic community, EPILEPSIA is categorized in the top quartile (Q1) in both neurology and clinical neurology as of 2023, underscoring its significance and prestige. The journal is ranked #15 out of 192 in Neuroscience & Neurology and #34 out of 400 in Medicine & Neurology (clinical) within Scopus, indicating its essential role in advancing knowledge and treatments related to epilepsy. Researchers and clinicians are encouraged to contribute groundbreaking studies, case reports, and reviews that inform best practices and improve patient outcomes. Although EPILEPSIA currently does not offer open access options, its detailed exploration of both fundamental and clinical aspects of epilepsy ensures wide dissemination of crucial findings among professionals and students alike, furthering the understanding and management of this complex condition.

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

Clinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.

The JOURNAL OF CHILD NEUROLOGY is a distinguished publication in the critical fields of neurology and pediatrics, published by SAGE PUBLICATIONS INC. With its ISSN 0883-0738 and E-ISSN 1708-8283, this journal has been a pivotal resource since its inception in 1986, serving the needs of researchers, clinicians, and students dedicated to advancing the understanding and treatment of neurological disorders in children. As evidenced by its impressive Q2 rankings in both Neurology (clinical) and Pediatrics, Perinatology, and Child Health, the journal has established a reputable position within the academic community, ranking in the 75th percentile for pediatrics and the 53rd percentile for clinical neurology. This periodical not only contributes to the body of knowledge in child neurology but also promotes interdisciplinary collaboration, engaging a global audience through innovative research articles and case studies. Although the journal is not open access, it remains committed to disseminating high-quality research aimed at improving pediatric health outcomes, making it an essential read for professionals and researchers dedicated to this crucial area of medicine.

REVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.

The Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.

EPILEPSY & BEHAVIOR is a premier journal dedicated to advancing the field of neurology and behavioral neuroscience, published by Academic Press Inc. Elsevier Science. With a focus on the complex interplay between epilepsy and behavioral disorders, this journal serves as a pivotal platform for researchers, clinicians, and educators alike. The journal holds a commendable position with a Q2 ranking in key categories such as Behavioral Neuroscience and Clinical Neurology, highlighting its influence and contributions to the scientific community. Notably, EPILEPSY & BEHAVIOR is indexed in Scopus, ranking in the top percentiles across various related fields, which underscores the quality and relevance of the research it publishes. As it navigates from its inception in 2000 to its ongoing work into 2024, the journal remains committed to disseminating high-quality research and insights that address critical issues in epilepsy and associated behavioral challenges, providing invaluable resources for ongoing education and innovation in the field.